Literature DB >> 31621699

H2O2-activated oxidative stress amplifier capable of GSH scavenging for enhancing tumor photodynamic therapy.

Yadong Liu1, Zhanwei Zhou1, Yidi Liu1, Yanhui Li2, Xinzhi Huang1, Chenggen Qian1, Minjie Sun1.   

Abstract

Photodynamic therapy (PDT) is a clinically approved cancer treatment approach that relies on the generation of excess reactive oxygen species (ROS) to eradicate tumor cells by inducing oxidative stress. Unfortunately, if the tumor's endogenous glutathione (GSH) is overexpressed, it will eliminate the ROS and restrict the therapeutic efficacy of PDT. Herein, we report a H2O2-activated oxidative stress amplifier (OSA) for enhancing the ROS generation for PDT via GSH scavenging. Cinnamaldehyde (Cin) and chlorin e6 (Ce6) were applied as the GSH scavenger and photosensitizer, respectively, which were assembled with the ROS-responsive amphipathic polymer (DPL) to form DPL@CC micelles as the OSA. In the circulation of blood, the OSA can effectively protect the Cin from albumin binding to retain its GSH depletion ability. Once the OSA reached the tumor site, the high level of H2O2 triggered the degradation of DPL and led to the release of Cin and Ce6. Subsequently, the released Cin reacted with the intracellular GSH by Michael Addition and downregulated the GSH level to about 18.9%, versus untreated cells, to weaken the anti-oxidation ability of tumor cells. Thus, it provided a suitable environment for PDT to obtain an amplifying effect on oxidative stress and superior anti-cancer efficacy of 94% growth inhibition. The preparation of the H2O2-activated oxidative stress amplifier is a convincing strategy for promoting intracellular ROS generation and enhancing the tumor PDT efficacy, which could also augment the clinical application of PDT.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31621699     DOI: 10.1039/c9bm01354g

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  4 in total

1.  GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer.

Authors:  Zhanwei Zhou; Hui Wu; Ruoxi Yang; Alan Xu; Qingyan Zhang; Jingwen Dong; Chenggen Qian; Minjie Sun
Journal:  Sci Adv       Date:  2020-09-02       Impact factor: 14.136

2.  Cell membranes targeted unimolecular prodrug for programmatic photodynamic-chemo therapy.

Authors:  Jie Yuan; Rong Peng; Dongdong Su; Xingxing Zhang; Hepeng Zhao; Xiujuan Zhuang; Mei Chen; Xiaobing Zhang; Lin Yuan
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

Review 3.  Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy.

Authors:  Xiangyu Deng; Zengwu Shao; Yanli Zhao
Journal:  Adv Sci (Weinh)       Date:  2021-01-05       Impact factor: 16.806

Review 4.  Enhancement of tumor lethality of ROS in photodynamic therapy.

Authors:  Lan Ming; Kai Cheng; Yu Chen; Rui Yang; Daozhen Chen
Journal:  Cancer Med       Date:  2020-11-03       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.